M4MM
Republican State AGs Challenge Trump’s Cannabis Rescheduling Directive
LOS ANGELES – A coalition of Republican attorneys general from eight states has publicly rejected President Donald Trump's recent Executive Order to reschedule Cannabis under the Controlled Substances Act, citing persistent risks to public safety ...
Banks Still Hesitant on Expanding Services for Cannabis Businesses Post-Trump Rescheduling Order
LOS ANGELES – President Donald Trump's Executive Order fast-tracked the move to reschedule Cannabis under the Controlled Substances Act, aiming to ease research barriers and tax deductions for state-legal operators. Yet even as this policy ...
Atai Gains Nasdaq Biotechnology Index Spot
NEW YORK – AtaiBeckley N.V., the clinical-stage biopharmaceutical firm born from the November merger of atai Life Sciences and Beckley Psytech, has secured a place in the Nasdaq Biotechnology Index (NBI), a move that underscores ...
Jushi Holdings Reports Q3 2025 Financial Results
LOS ANGELES – Jushi Holdings Inc., a vertically integrated Cannabis operator with footprints in six states, disclosed third-quarter 2025 financials that showed revenue climbing 6.6% year-over-year to $65.7 million, driven by higher wholesales and customer ...
Compass Pathways Advances Psilocybin Therapy Timeline for Depression Treatment
LONDON & NEW YORK – Compass Pathways reported Q3 2025 financial results and signaled a faster path to market for its lead psilocybin-based therapy in treatment-resistant depression (TRD). The biotechnology firm now targets commercialization readiness ...
Missouri Trade Group Report Finds 96% of Tested Hemp Products Exceed THC Thresholds
KANSAS CITY – A new investigation by the Missouri Cannabis Trade Association (MoCannTrade) has concluded that nearly all hemp-derived products sold at unregulated retailers in the state contain illegal levels of THC, raising questions about ...
New Mexico Cannabis Market Edges Toward $2B in Total Sales
ALBUQUERQUE – New Mexico's Cannabis industry has recorded $1.9 billion in combined medical and adult-use sales since recreational legalization took effect in April 2022, according to the latest figures from the state’s Regulation and Licensing ...
Republican State AGs Challenge Trump’s Cannabis Rescheduling Directive
LOS ANGELES – A coalition of Republican attorneys general from eight states has publicly rejected President Donald Trump's recent Executive Order to reschedule Cannabis under the Controlled Substances Act, citing persistent risks to public safety ...
Banks Still Hesitant on Expanding Services for Cannabis Businesses Post-Trump Rescheduling Order
LOS ANGELES – President Donald Trump's Executive Order fast-tracked the move to reschedule Cannabis under the Controlled Substances Act, aiming to ease research barriers and tax deductions for state-legal operators. Yet even as this policy ...
Atai Gains Nasdaq Biotechnology Index Spot
NEW YORK – AtaiBeckley N.V., the clinical-stage biopharmaceutical firm born from the November merger of atai Life Sciences and Beckley Psytech, has secured a place in the Nasdaq Biotechnology Index (NBI), a move that underscores ...
MindMed Launches $75 Million Public Offering to Fund Psychedelic Research
LOS ANGELES- Mind Medicine (MindMed) Inc. announced a public offering aimed at raising $75 million through the sale of approximately 9.2 million shares at $7 each. The company is also offering around 1.4 million shares ...
Green Thumb Industries Reports Strong Q2 2024 Performance
LOS ANGELES- Green Thumb Industries Inc. a Chicago-based cannabis company, posted solid second-quarter results for 2024, with revenue climbing 11% year-over-year to $280 million, exceeding analyst forecasts of $277.36 million. The company’s net income rose ...
atai Life Sciences Reports Q2 2024 Financial Results
LOS ANGELES- atai Life Sciences, a biopharmaceutical company focused on transforming mental health treatment, announced its financial results for the second quarter of 2024 along with updates on its clinical pipeline. The company highlighted significant ...
TerrAscend Corp. Announces $10 Million Share Buyback Program
LOS ANGELES- TerrAscend Corp., a prominent North American cannabis company, has initiated a normal course issuer bid (NCIB) to repurchase up to $10 million of its common shares over the next 12 months. The program, ...
Sumitomo Mitsui Trust Holdings Reduces Stake in COMPASS Pathways by 11.8% in Q2
LOS ANGELES- Sumitomo Mitsui Trust Holdings Inc. has reduced its stake in COMPASS Pathways plc (NASDAQ: CMPS) by 11.8% during the second quarter, according to a recent filing with the Securities and Exchange Commission (SEC). ...
BudLabs: The App Innovating How Cannabis Cultivators Measure Their Success
LOS ANGELES — In cannabis cultivation, staying ahead of the curve requires not only the best products but also the best tools. Advanced Nutrients has taken a significant step in this direction with the development ...
Out-of-State Applicants Dominate Minnesota’s Early Cannabis License Applications
LOS ANGELES- Minnesota's newly established cannabis market is attracting significant interest from out-of-state applicants, according to recent data from the Office of Cannabis Management (OCM). Of the 1,817 pre-applications submitted this summer for various cannabis ...
Bipartisan Lawmakers Push for MDMA Therapy for PTSD as FDA Decision Looms
LOS ANGELES- In a rare show of bipartisanship, 80 members of Congress have united to urge President Joe Biden and the FDA to prioritize research on MDMA-assisted therapy for treating post-traumatic stress disorder (PTSD). The ...
Morocco Pardons 5,000 for Illegal Cannabis Cultivation in Push Toward Legal Market
LOS ANGELES- Morocco’s King Mohammed VI has pardoned nearly 5,000 individuals previously convicted or wanted for illegal cannabis cultivation, a move aimed at facilitating the transition to the legal cannabis market. The royal pardon is ...
Willow Biosciences Posts Record Revenue in Q2
LOS ANGELES- Willow Biosciences Inc. a synthetic biology company specializing in pharmaceutical ingredients, reported record revenue of $1 million for the second quarter of 2024, a 660% increase compared to the same period last year. ...
New York Cannabis Market Report Highlights Progress and Challenges
LOS ANGELES- New York state officials released a comprehensive report this week, reviewing the progress made in the three years since the state's cannabis legalization law was signed by then-Governor Andrew Cuomo in 2021. The ...
Week’s In Review: Federal Policy Uncertainty Continues to Challenge U.S. Cannabis Industry; LeafLink Acquires Leaf Trade to Enhance Cannabis Wholesale Platform; Canopy Growth Appoints New CEO Amid Financial Challenges; New York’s Legal Cannabis Sales Approach $1 Billion Milestone
LOS ANGELES — Welcome to the far too-exciting world of cannabis and psychedelics, where it’s a tale of two markets with some states doing amazingly well. And some, well...they're not doing so well (hello New ...
Week’s In Review: GOP Senator Calls for Comprehensive Cannabis Reform, Criticizes Partial Measures; MAPS Wins FDA Approval for Clinical Trials of Medical Cannabis; Curaleaf Secures Massachusetts’ First Cannabis Research License
LOS ANGELES — Welcome to the far too-exciting world of cannabis and psychedelics, where it’s a tale of two markets with some states doing amazingly well. And some, well...they're not doing so well (hello New ...
Week’s In Review: How Do You Target the Right SEC-Accredited Investors in Cannabis?; Amethyst Health Secures Conditional Medical Cannabis License in New York; California’s Cannabis Excise Tax Set to Increase Amid Industry Concerns
LOS ANGELES — Welcome to the far too-exciting world of cannabis and psychedelics, where it’s a tale of two markets with some states doing amazingly well. And some, well...they're not doing so well (hello New ...
Week’s In Review: Trump’s Return to Office: What it Means for the Cannabis Industry; Planet 13 Launches Initiative to Support Florida Veterans and First Responders with Medical Cannabis Access; Mixed Results for Cannabis Initiatives in U.S. States; Texas Voters Approve Local Cannabis Decriminalization in Dallas, Bastrop, and Lockhart
LOS ANGELES — Welcome to the far too-exciting world of cannabis and psychedelics, where it’s a tale of two markets with some states doing amazingly well. And some, well...they're not doing so well (hello New ...
